Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Inv. presentation Cert. of designation Director departure Asset disposition Notes underwriting agrmnt
|
Rennova Health, Inc. (RNVA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/21/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
08/15/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
05/16/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/15/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
05/09/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
04/24/2023 |
8-K
| Quarterly results |
04/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
02/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
12/30/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
11/23/2022 |
8-K
| Quarterly results |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
10/20/2022 |
8-K
| Quarterly results |
09/23/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
09/14/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
06/16/2022 |
8-K
| Quarterly results |
05/23/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
04/27/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
04/15/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
04/07/2022 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
04/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
03/31/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
03/17/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
03/16/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs:
|
"RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. – Rennova Health, Inc. , today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 , the Company completed a 1 for 10,000 reverse stock split of its outstanding common stock. The Company’ s common stock will open for trading on Wednesday March 16, 2022, on a post-split basis and trade under the symbol RNVAD for 20 days. As a result of the reverse stock split, every 10,000 shares of the Company’ s common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share, except to the extent that the reverse stock split results in any of the Company’ s stockholders owning a fractional share, which fractional share will be in that case paid in cash. In connecti..." |
|
03/10/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
02/01/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs:
|
"FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of January 31, 2022, between Rennova Health, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act , and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and..." |
|
12/17/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events Interactive Data |
12/17/2021 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
12/16/2021 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
12/13/2021 |
8-K
| Quarterly results |
11/26/2021 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
|
|
|